glp-1 acronym once a weird now prominent in the nutrition conversation. Only to get larger as the form factor shifts beyond injections. We've heard estimates of 30m users by 2035. By design… GLP-1 | Summary

As GLP-1 RAs are contraindicated for people with gastrointestinal disease, pancreatitis, or a family history of mutations in multiple endocrine neoplasia type 2/medullary thyroid carcinoma (MEN2/MTC), SGLT2i is the preferred treatment for these patients groups

Community reports suggest possible benefits, but essentially zero quality human trials exist

GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide are backed by STEP ( The New England Journal of Medicine , 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024)

It can pair well with strength training, fasted cardio, daily steps, or general fitness routines where consistency matters more than quick effects

Topamax may not result in weight loss for everyone

(agosto de 2015)